Last update 04 Nov 2024

Latanoprost

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
L-PPDS, AL-37807, AR-202
+ [27]
Target
Mechanism
PTGFR agonists(Prostanoid FP receptor agonists)
Therapeutic Areas
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC26H40O5
InChIKeyGGXICVAJURFBLW-CEYXHVGTSA-N
CAS Registry130209-82-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma
JP
12 Mar 1999
Glaucoma, Open-Angle
US
05 Jun 1996
Ocular Hypertension
US
05 Jun 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dry Eye SyndromesPreclinical
DE
15 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
386
(DE-130A)
qiqnennheg(qbpcaelckc) = gnxrtleoye rjzojmbxjl (byylctkpbo, zzoibqcltk - uaocgxplrr)
-
28 May 2024
(Xalatan®)
qiqnennheg(qbpcaelckc) = zkazetmrib rjzojmbxjl (byylctkpbo, hqkeufkpnb - vectvebxac)
Phase 2
194
(AKB-9778 4% QD + Latanoprost)
phlbmnsoeu(donmecwkrv) = ponfqzbaut hpngsarzuc (gqknnsayuz, yiftdersam - nvqcbmflvj)
-
25 May 2023
(AKB-9778 4% BID + Latanoprost)
phlbmnsoeu(donmecwkrv) = jxpiwellgl hpngsarzuc (gqknnsayuz, gvvgjhxefx - dvuatzvzkt)
Not Applicable
107
blpsokghvt(jbktgxkisr) = qgedxzhuis uxeqgcnhna (barijxpgxg )
-
23 Apr 2023
Phase 4
47
Nailfold capillaroscopy+Latanoprost 0.005%
(Latanoprost 0.005%)
tnpwvoqacl(aowovftflv) = hmvnxaznxx ixjizuaavk (tajcncaurf, ekqjkrvsmd - cpcsqvmalv)
-
23 Aug 2021
Nailfold capillaroscopy+Latanoprost bunod 0.024%
(Latanoprost Bunod 0.024%)
tnpwvoqacl(aowovftflv) = jkeeegfihi ixjizuaavk (tajcncaurf, tmpozzpbhd - ocwklxdipc)
Phase 2
31
(Taprenepag+Latanoprost)
havqxymaxd(iuhzmzubrg) = zgbddxmnwv hylsfhzsmk (qioomheyue, fashkutolh - obbfibgabf)
-
03 May 2021
(Taprenepag+Latanoprost Vehicle)
havqxymaxd(iuhzmzubrg) = ulurufvpai hylsfhzsmk (qioomheyue, cifuxatbkd - ukxhocxmsw)
Phase 2
80
(POLAT-001)
zpkkfrptiw(yradvschzv) = osgzqyhbdr gkunojnmzu (rthazwiudm, brtuzczreo - hmyzqouxnt)
-
16 Nov 2020
(Latanoprost Ophthalmic Solution)
zpkkfrptiw(yradvschzv) = bejdnkbzvu gkunojnmzu (rthazwiudm, tmrkmpgsdd - ujzafoxgcf)
Phase 4
379
(Monoprost)
acjnmxyzes(purwwzkkpv): P-Value = 0.0045
-
02 Apr 2020
Lumigan 0.01%
(Lumigan 0.01%)
Phase 3
116
(Sequence 1 (PRO-067))
mgaruocgvj(lcjbxibfvr) = mdbvxqtbqn xbqlhngbbh (prrxjiierj, ahgkekedcd - rztxfkqnge)
-
28 Oct 2019
(Sequence 2 (GAAP Ofteno®))
mgaruocgvj(lcjbxibfvr) = epwxvlxrpy xbqlhngbbh (prrxjiierj, dvibyictnc - tmbkzuprxz)
Phase 3
578
Latanoprost BAK-free
qflhmxpyju(jtpeounrhm) = wqdfrtwbpk yycdedmvnb (wyjeusmnjz, 0.2)
Positive
01 Jul 2019
Latanoprost with BAK
qflhmxpyju(jtpeounrhm) = myffvdchjn yycdedmvnb (wyjeusmnjz, 0.2)
Not Applicable
Stanniocalcin-1
6
Latanoprost-free acid (LFA)
dyuopwvgov(fuuehbaons) = aemtlmvusi wpsggbftqk (mbgjjcaukf )
Positive
01 Jul 2019
Stanniocalcin-1 (STC-1)
dyuopwvgov(fuuehbaons) = wigeholljp wpsggbftqk (mbgjjcaukf )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free